Rapid development of bacterial resistance has led to an urgent need to find new druggable targets for antibiotics.In this context, residue-specific chemoproteomic approaches enable proteome-wide identification of binding sites for covalent inhibitors.D escribed here are easily synthesized isotopically labeled desthiobiotin azide (isoDTB) tags that shortened the chemoproteomic workflowa nd allowed an increased coverage of cysteines in bacterial systems.They were used to quantify 59 %o fa ll cysteines in essential proteins in Staphylococcus aureus and enabled the discovery of 88 cysteines that showed high reactivity,w hichc orrelates with functional importance.F urthermore,2 68 cysteines that are engaged by covalent ligands were identified. Inhibition of HMG-CoA synthase was verified and will allow addressing the bacterial mevalonate pathway through an ew target. Overall, ab road map of the bacterial cysteinome was obtained, which will facilitate the development of antibiotics with novel modesof-action.
Introduction
Infections with multidrug-resistant bacteria like methicillin-resistant Staphylococcus aureus (MRSA) are emerging as major threats to human health. [1] Nevertheless,very few novel classes of antibiotics have been introduced to clinics over the last decades. [1] Furthermore,a lmost all approved antibiotics exclusively interfere with avery limited set of bacterial targets involved in protein, nucleic acid, and cell wall biosynthesis. [1] Therefore,d eveloping innovative methods to discover novel druggable targets for antibiotics is apivotal task to guarantee efficient treatment of bacterial infections in the future.
Chemoproteomic approaches are extremely powerful for understanding which proteins are able to bind small molecules as ligands [2] and are particularly straightforward for covalently reactive molecules. [2a,c,d] Strikingly,covalent inhib-itors have seen ar esurgence of interest for the development of novel drugs as they can increase compound selectivity, reduce resistance formation, and target shallow protein pockets. [3] This interest has led to the recent clinical approval of several covalent kinase inhibitors. [4] Especially in the field of antibiotics,covalent inhibitors are prevalent as exemplified by b-lactams, [3] fosfomycin, [5] showdomycin, [6] and optimized arylomycins. [7] Recently,m ethods have emerged to globally identify the exact interaction site of covalent inhibitors in ac ompetitive fashion. [2a,b,8] In this way,many pockets that can bind covalent ligands are identified in parallel using as mall library of covalently reactive molecules.T his technology is especially well established for profiling cysteine residues using methods based on the isoTOP-ABPP (isotopic tandem orthogonal proteolysis activity-based protein profiling) platform (Figure 1a ). [2a] In this technology,aproteome of interest is split into two samples.O ne of these samples is treated with ac ovalent inhibitor and the other one with DMSO as ac ontrol. In the next step,b oth samples are treated with iodoacetamide alkyne (IA-alkyne). [9] This probe will modify many cysteines in both samples with alkynes and this reactivity will be blocked by the covalent inhibitor at its specific binding sites.T he samples are next modified with isotopically labeled affinity tags using copper-catalyzed azide-alkyne cycloaddition (CuAAC). [10] Thes amples are combined, enriched on streptavidin beads,p roteolytically digested and the modified peptides eluted for mass spectrometry (MS) based quantification. Most quantified cysteines will have ratios R % 1b etween the heavy and light channel indicating no interaction with the covalent compound ( Figure 1a ). In contrast, cysteines at the specific binding sites will show ratios of R @ 1. In this way,quantitative and site-specific interaction studies in the whole proteome are possible with unmodified covalent inhibitors that do not need to be equipped, for example,with an affinity handle.
In the last step of this protocol, the modified peptides need to be eluted from the streptavidin beads for MS-based analysis.Asprevious studies have utilized biotin, which binds almost irreversibly to streptavidin, as an affinity handle, various cleavable linkers have been applied to elute the peptides from the beads. [11] These linkers include those that are cleaved by proteases ( Figure 1b ), [2a, 9] acidic, [11b, 12] or reductive conditions. [11b,13] Because of the high requirements on the orthogonality of these linkers,they need to be designed very carefully,w hich usually requires laborious multistep synthesis of the tags.Furthermore,the cleavage of the linker adds another step to the chemoproteomic protocol.
Therefore,w es et out to develop isotopically labeled desthiobiotin azide (isoDTB) tags ( Figure 1c )f or residue-specific proteomics.Asdesthiobiotin still binds very strongly to streptavidin, all steps up to the proteolytic digestion can be kept the same. [14] Because of the reversibility of binding of desthiobiotin to streptavidin, in the last step,the peptides are then easily eluted using acidic conditions with acetonitrile as the cosolvent. [14] Because ac omplex cleavable linker is not needed, we designed these tags exclusively with two isotopically differentiated glycine residues as the linker moiety.
After establishing the utility of the isoDTB tags for residue-specific proteomics,w eu sed them to globally investigate cysteines in the proteome of S. aureus for their reactivity and their potential to bind covalent ligands.Inthis way,weidentified 88 highly reactive cysteines and more than 250 cysteines that can be addressed with covalent ligands. These residues are starting points for the development of antibiotics with novel modes-of-action.
Results and Discussion
We synthesized the isoDTB tags using solid-phase peptide synthesis.F or this purpose,aR ink amide resin and an Fmoc strategy were utilized. We sequentially coupled e-azido-lysine, two glycine residues,and desthiobiotin. We used glycine with the natural isotope distribution for the light isoDTB tag and glycine with two 13 Ca toms and one 15 Na tom for the heavy tag. In this way,atotal mass difference between the tags of 6Daw as obtained. Purification by RP-HPLC resulted in ay ield of approximately 70 %for both isoDTB tags.
To establish that the tags are applicable to broadly investigate cysteines in ap roteomic context, we treated two identical samples of the lysate of the methicillin-sensitive S. aureus (MSSA) strain SH1000 [15] with 1mm IA-alkyne and modified the two samples with the light and heavy isoDTB tag, respectively,using CuAAC. Thesamples were combined either in ar atio of 1:1o r1 :4. Subsequently,w ee nriched the samples on streptavidin beads,d igested the proteins with trypsin, and eluted the modified peptides using our straightforward approach. Analysis using liquid chromatography coupled to tandem MS (LC-MS/MS) using aQExactive Plus (Thermo Fisher) mass spectrometer and evaluation using freely available MaxQuant software [16] identified 1155 cys- Figure 1 . a) Workflow for competitive, residue-specific chemoproteomic experiments. [2a] RG = reactive group, AH = affinity handle. b) Structureo f the TEV protease-cleavable tags (TEV tags) originally used for residue-specific proteomics. [2a, 9] c) Structure of the isoDTB tags developed in this study. teines that were quantified for both conditions (Figure 2a ;see Table S1 ). This analysis revealed anarrow distribution of the detected ratios for both samples around the expected values. TheisoDTB tags therefore reliably allowed quantification of cysteines in the whole bacterial proteome.
We next benchmarked our technology against the TEV protease-cleavable biotin tags (TEV tags) that have been most broadly used to residue-specifically map proteomes ( Figure 2b ;see Table S1 ). [2a,9] Our isoDTB tags outperformed the TEV tags by quantifying 27 %m ore cysteines in the S. aureus proteome.W ei ncreased the number of cysteines quantified with the isoDTB tags even more by additionally using chymotrypsin and AspN for the proteolytic digest (see Figure S1 and Table S1 ). These experiments are not possible for the TEV tags as these proteases would cleave the tag itself. In this way,w eq uantified at otal of 1643 cysteines in the S. aureus proteome using the isoDTB tags in only six experiments.W enext investigated the performance of the isoDTB tags with IA-alkyne in different Gram-positive and Gramnegative bacteria (Figure 2c ;s ee Table S1), and consistently quantified more than 1000 cysteines in each strain. Moreover, we were able to quantify more than 3500 cysteines in the human cell line MDA-MB-231, which is competitive with previously described methods. [2a] Therefore,our isoDTB tags not only shortened the chemoproteomic protocol but also led to increased coverage in bacterial systems compared to the widely used TEV tag technology.
We next applied our method to analyze the reactivity of cysteines in the bacterial proteome ( Figure 3a ). [9a] As the reactivity of cysteines is linked to their functional relevance in human cells, [9a] we reasoned that this feature might also be conserved in bacteria and in this way lead to the identification of functionally important cysteine residues.T ostudy cysteine reactivity,t wo identical samples of the proteome of the S. aureus strain SH1000 were treated with either ah igh (100 mm)oralow (10 mm)concentration of IA-alkyne.Inthis way,w hile at the high concentration many cysteines were labeled, at the low concentration only the most reactive cysteines were labeled quantitatively.After CuAACwith the light (low concentration) and heavy isoDTB tags (high concentration), respectively,t he samples were analyzed in the same way as described above.H ere,h igh ratios (R 10:1 ) indicate low reactivity cysteines,w hereas the most reactive cysteines have R 10:1 % 1. Using this procedure,w eq uantified 921 cysteines and identified 88 highly reactive cysteines with R 10:1 < 3i n6 9d ifferent proteins ( Figure 3b ;s ee Table S2 ). Another 240 cysteines showed medium reactivity (3 < R 10:1 < 5), whereas the remaining 593 cysteines were of low reactivity (R 10:1 > 5). Cysteines of all three bins of reactivity were evenly distributed throughout the different functional classes of proteins (see Figure S2 ). [18] Interestingly,h ighly reactive cysteines were depleted in essential proteins [17] in comparison to their counterparts of lower reactivity (Figure 3c ). It can be speculated that evolutionary pressure has selected against highly reactive cysteines in essential proteins as these would interact with many reactive small-molecule electrophiles that occur in nature.
There is as trong enrichment of the highly and medium reactive cysteines at functional sites ( Figure 3d ). These cysteines include many residues that are directly involved in the catalytic mechanism (e.g.C178 in the GTP cyclohydrolase FolE2 (UniProt code Q2G0L1), [19] C112 in FabH (UniProt Figure 3 . a) Workflow for the measurementofcysteine reactivity using the isoDTB tags. [9a] DTB = desthiobiotin.b )Plot of the reactivity ratios (R 10:1 )o btained by comparing S. aureus SH1000 proteomes treated with high (100 mm) vs. low concentration (10 mm)ofIA-alkyne (black). Ratios (R 1:1 )o fanexperiment with high concentration used for both samples (grey) are used as acontrol to ensure reliable quantificationo fa ll cysteines.c ,d) Percentage of cysteines in the different reactivity bins that are in essential proteins (c) [17] or at functionalsites (d).
code Q2FZS0), and C88 in the probable acetyl-CoA acyltransferase (UniProt code Q2G124), which are all essential proteins). Furthermore,s everal highly reactive cysteines are close to cofactor-binding sites (e.g. C239 of the CTP synthase PyrG (UniProt code Q2FWD1), and C45 in MnmG (UniProt code Q2FUQ3)) or metal-binding sites (e.g.C 145 of alcohol dehydrogenase Adh (UniProt code Q2G0G1), and C65 of biotin synthase BioB (UniProt code Q2FVJ7)). Therefore, residue-specific proteomics using our isoDTB tags allowed global profiling of the reactivity of cysteines in the bacterial proteome and enabled the identification of functionally relevant residues.
We next set out to study which cysteines in the S. aureus proteome can be targeted with covalent ligands.F or this purpose,w eo btained al ibrary of 211 electrophilic cysteinedirected compounds (EN001-EN211;s ee Table S3 ), mainly a-chloroacetamides.T hese compounds were initially screened for antibacterial activity by performing minimum inhibitory concentration (MIC) experiments.W hile we did not expect these small compounds to be completely specific, we used this phenotypic pre-filter to prioritize compounds, whose target spectrum includes essential proteins that can be addressed in intact cells.B ased on an initial screen in three MSSA strains,w es elected 24 compounds (see Figure S3 ) based on their MIC values and structural diversity for further studies.I nterestingly,m any of these compounds contain a 2-aminothiazole moiety,w hich seems to be beneficial for activity.2 3c ompounds had MICs of 100 mm in all three strains with six compounds having MICs of 12.5 mm in all three strains (see Figure S4 ). Furthermore,1 4c ompounds showed activity (MIC 100 mm)intwo tested MRSA strains with two compounds (EN085 and EN177)h aving an MIC 10 mm in all five tested strains.T his data shows that electrophilic compounds with desired biological activity could efficiently be identified from asmall compound library.
Thes elected 24 compounds were screened at a2 00 mm concentration in residue-specific chemoproteomic experiments using our isoDTB tags in duplicates (Figure 1a ;s ee Figure S5 and Figure S6 ). Fort hree of the compounds (EN007, EN085 and EN177), we performed an additional set of biologically independent duplicates.G iven the high reproducibility between the biologically independent experi-ments (see Figure S5 ), we performed the remaining profiling in duplicates and prioritized screening more compounds over performing more replicates.F ive of the compounds (EN007, EN085, EN135, EN177,and EN201)that showed MIC values 25 mm in all five tested strains were additionally tested at 20 mm concentration (see Figure S7 ).
In all experiments,weconsider cysteines that have aratio of R > 4( log 2 (R) > 2) and whose R value is statistically significantly different from R = 1( p-value < 0.05 in ao nesample t-test), to be engaged by the covalent ligand. We identified alarge range of values for the fraction of cysteines that are engaged by the different compounds (Figures 4a-c; see Figure S6 and Figure S8a ). Nine compounds showed low promiscuity (< 2% of all quantified cysteines are engaged, Figure 4a ), ten compounds showed medium promiscuity (2 % to 10 %, Figure 4b ), and five compounds showed excessive promiscuity (> 10 %, Figure 4c ). Strikingly,n oc orrelation between MIC and promiscuity could be observed (see Figure S8b ), indicating that it is possible to identify highly active and still selective electrophiles.A swec annot rule out unspecific effects for the highly promiscuous compounds,w e excluded these from all further analysis.W hile the low promiscuity compounds are most interesting for further compound development, the medium promiscuity compounds are most useful for the global profiling approach performed here.
Taking all 25 investigated conditions together (19 compounds at 200 mm,f ive compounds at 20 mm, and aD MSO control), we compiled acompetitive data table (see Table S4 ), which includes all cysteines that were quantified for at least three of the conditions.Inthis way,weobtained information on 1756 cysteines in 905 different proteins,which corresponds to ac overage of 33 %o fa ll the cysteines encoded in the S. aureus genome.A sc ysteines in essential proteins [17] are enriched in our data over the genomic background (see Figure S9a ), this equates to the quantification of 59 %o fa ll cysteines in essential proteins.E ach cysteine was quantified on average for 21 of the 25 conditions (see Figure S10 ). Therefore,o ur method allowed obtaining information on many cysteine residues in S. aureus in areproducible manner.
268 cysteines in 200 different proteins were engaged by at least one ligand (Figure 5a ). In many proteins,wedetect one ligandable cysteine that is engaged by several compounds, while the other cysteine(s) are never engaged (see Figure S11 ). This observation indicates that our method measures local target engagement of the cysteines rather than global changes to the protein structure.W hile ligandable cysteines are enriched in enzymes,w ea lso identify them in other functional classes of proteins (see Figure S12 ). [18] Ligandable cysteines are enriched at functional sites (see Figure S13 ) and similarly abundant in essential proteins as compared to other quantified cysteines (see Figure S9b ). When we compared this data to the cysteine reactivity data (see Figure S14 ), we could see that, while the highly reactive cysteines are clearly more likely to be ligandable,t here are also many ligandable cysteines of medium and low reactivity, indicating that specific noncovalent interactions are important in these cases.
Next, we looked at the binding of our covalent ligands to aselection of ligandable cysteines in more detail (Figure 5b ). While the most ligandable cysteines tend to be engaged by the most promiscuous compounds,t here is clear evidence for more specific interactions between less ligandable cysteines with more selective compounds.F or example,t he active site residue C112 of FabH (UniProt code Q2FZS0), an essential enzyme in fatty acid synthesis, [20] is exclusively targeted by three compounds of tempered promiscuity (EN002, EN204 and EN208,F igure 5b). This residue has previously been shown to be covalently modified for example,b yt he inhibitors 4,5-dichloro-1,2-dithiol-3-oneand cerulenin. [21] Furthermore,the residue C323 in the isoleucine-tRNAligase IleS (UniProt code Q2FZ82) is only targeted by another set of three compounds (EN012, EN077 and EN201,F igure 5b), which could open up the possibility of inhibiting bacterial translation through an ovel target. Overall, we detect many binding events that are strongly dependent on the compound and on the targeted cysteine indicating that our method can detect specific ligand-binding events.
Looking at the targets of the two compounds that showed the best antibacterial activity in the initial MIC assays (EN085 and EN177,F igure 5c,d), we saw that both compounds show engagement of several cysteines at 20 mm (31 for EN085,1 0 for EN177). Both compounds strongly target C152 of MurC (UniProt code Q2FXJ0), which is akey enzyme essential for cell wall synthesis. [22] EN177 additionally binds to C410 of pyruvate kinase (UniProt code Q2FXM9) and C88 of the essential probable acetyl-CoA acyltransferase (UniProt code Q2G124). Thel atter cysteine forms an acyl-thioester intermediate during catalysis. [23] EN085 binds to C1030 in the DNApolymerase PolC (UniProt code Q2G1Z8), C199 in the tRNA-specific methyl transferase MnmA (UniProt code Q2FXV6), which forms ac ysteine persulfide intermediate during catalysis, [23] as well as the catalytically active nucleophile C151 in glyceraldehyde-3-phosphate dehydrogenase (UniProt code Q2G032). [24] Both compounds,therefore,bind to several essential target proteins that have the potential to become novel targets of covalent antibiotic compounds.
To investigate if the results obtained in the MSSA strain SH1000 are transferable to other S. aureus strains,compounds EN085 and EN177 were additionally screened at 20 mm in the MRSA strain USA300, for which they show MIC values of 6.3 mm and 3.1 mm,respectively (see Figure S15 and Table S5 ). We detect avery good correlation of the data obtained in the two different strains (see Figure S16 ). All cysteines in essential proteins discussed above were also engaged by the same compound in USA300. While no new engaged cysteines were identified for EN177,w ei dentified five additional engaged cysteines for EN085 in USA300 that were not quantified at all in SH1000. Among those,two cysteines are in essential proteins. [17] EN085 binds to the active site C119 in MurA (UniProt code A0A0H2XGP3), which is akey enzyme in cell wall biosynthesis [22] and also targeted by fosfomycin. [5] Additionally,C 565 in the aspartate-tRNAl igase AspS (Uni-Prot code Q2FG97) is modified by EN085,w hich opens up the possibility to target translation through an ovel mechanism. Thehighly reproducible results between the MSSA and MRSA strains demonstrate that our data delivers ab roadly applicable map of ligandable cysteines in the S. aureus proteome that will guide the design of antibiotics with novel modes-of-action.
To validate the interaction of aselected compound with an identified ligandable cysteine,w ei nvestigated C111 of the putative HMG-CoA synthase (UniProt code Q2FV76), which is an essential enzyme in the mevalonate pathway and in this way might open up targeting bacteria through this so far clinically unexplored pathway. [25] In gel-based experiments (Figure 6a ;see Figure S17 ), strong labeling by IA-alkyne was observed for the recombinant wildtype protein, but not for the C111A mutant. This data is in good agreement with the high reactivity of C111 (R 10:1 = 0.84) in the reactivity experiments ( Figure 3 ; see Table S2 ). Furthermore,t he low promiscuity compound EN106 that we identified to target HMG-CoA synthase (Figure 4a )b locked labeling at low micromolar concentrations,i ndicating covalent binding of this compound to C111. Using intact protein MS (IPMS,F igure 6b;s ee Figures S18 and S19), we detected quantitative single modification of the HMG-CoA synthase wildtype with EN106.Nomodification of the C111A mutant was detectable, Figure 6 . a) Result of gel-based labelingexperiments with HMG-CoA synthase. 1 mm recombinantw ild-type (WT) HMG-CoA synthase was added into 1mgmL À1 soluble lysate of S. aureus SH1000. As controls, 1 mm of the HMG-CoA synthase mutant (C111A) or no HMG-CoA synthase (none) were added.T he samples were treated with the indicated concentrations of EN106 or with DMSO as control. The samples were labeled with IA-alkyne and modified with TAMRA-azide using CuAAC. Analysis using SDS-PAGE with subsequent in-gel fluorescence scanning and Coomassie staining is shown. b) IPMS analysis of the modification of HMG-CoA synthase by EN106.1mm HMG-CoA synthase wildtype (WT) or mutant (C111A) was treated with DMSO as control or 10 mm EN106.D econvoluted IPMS spectra are shown. The mass differencebetween the wildtype treated with EN106 or DMSO (Dm = 258 Da) exactly corresponds to the modification of the protein with one moleculeo fEN106.c)Resultso factivity assays with HMG-CoA synthase. 1 mm HMG-CoA synthase wildtype (WT) was treated with 10 mm EN106 or DMSO as acontrol. Acetyl-CoA, acetyl-CoA-acyl-transferase (ACAT) and Ellman's reagent were added and the reaction progress was followed by measuringthe absorbancea t 410 nm over time. HMG-CoA synthase activity was calculated by al inear fit of the linear portion of this curve. Controls with the HMG-CoAs ynthase mutant (C111A), no HMG-CoA synthase or no acetyl-CoA-acyl-transferase (no ACAT) were included.T he graph shows mean AE standard deviation. All data results from triplicates. mAU:m illi absorbanceunits. strongly indicating that C111 is the site of covalent modification with EN106.T os tudy the activity of HMG-CoA synthase (Figure 6c ;see Figure S20 ) we set up acoupled assay with acetyl-CoA-acyl transferase (ACAT). [26] ACAT forms acetoacetyl-CoA from two molecules of acetyl-CoA. HMG-CoA synthase then catalyzes the reaction with another molecule of acetyl-CoA to give HMG-CoA. Thef ree thiol group of the CoA-SH liberated in both steps was detected using Ellmansr eagent (Figure 6c ). Addition of wild-type HMG-CoA synthase to the assay strongly increased the formation of free CoA-SH over the ACAT background reaction. This activity was reduced to the level without HMG-CoA synthase,when the C111A mutant was used or when the wildtype was pretreated with 10 mm EN106. EN106 had no effect on the detected ACAT activity in absence of HMG-CoA synthase or presence of the inactive C111A mutant (see Figure S21 ), showing that EN106 does not inhibit the ACAT reaction or hinder detection by alkylation of the free CoA-SH or the product of the Ellmansr eagent. Furthermore, inhibition remained after gel-filtration to remove excess free EN106,showing irreversible inhibition and further excluding interference of EN106 with other components of the assay (see Figure S22 ). Covalent modification of HMG-CoA synthase at C111 with compound EN106 therefore led to effective inhibition of its activity.H MG-CoA synthase is therefore ap romising target for the development of novel antibiotics that interfere with the essential mevalonate pathway.
Conclusion
We describe the synthesis of isotopically labeled desthiobiotin azide (isoDTB) tags and their application in chemoproteomic experiments.These tags were easily synthesized by solid-phase peptide synthesis in high yields and showed excellent physicochemical properties.Byusing desthiobiotin, these tags circumvented the need to use complex cleavable linkers [11a] for peptide elution and thus significantly shortened the chemoproteomic protocol, while increasing the coverage of cysteines in the proteome of S. aureus. Thei soDTB tags allowed quantification of many cysteines across different Gram-positive and Gram-negative bacterial proteomes and gave results comparable to the TEV tags,a lso in the human proteome. [2a] Because of the easy synthesis of the tag, the shortened workflow,t he use of freely available MaxQuant data evaluation software, [16] and the excellent performance, this technology will make residue-specific proteomics applicable in many laboratories not specialized in chemoproteomics.
Thei soDTB tags were applied to study the reactivity of cysteines in the proteome of S. aureus. We identified 88 highly reactive cysteine residues that are strongly enriched at functional sites of proteins.T his enrichment indicates that the reactivity of cysteines is ap roxy for the functional relevance of certain residues also in bacterial proteomes. Interestingly,h ighly reactive cysteines were less likely to be found in essential proteins,pointing to the fact that evolution may have selected against highly reactive cysteines in essential proteins to protect bacteria from the influence of reactive electrophiles occurring in nature either during metabolism or as environmental chemicals.
Finally,weapplied the isoDTB tags to broadly understand which cysteines in the bacterial proteome can be engaged with covalent ligands.F or this purpose,w ec ompiled competitive data for 19 a-chloroacetamides and profiled 1756 cysteines, including 59 %o fall cysteines in essential proteins.W e identified 268 cysteines that can bind covalent ligands in 200 different proteins.T he targeted cysteines include many functionally relevant residues in essential proteins involved in many different pathways.I nt his way,t he data presented will be the starting point for more specific covalent inhibitors to develop antibiotics with novel modes-of-action. The presented isoDTB tags will allow monitoring of the on-and off-target effects of the compounds and in this way streamline the development process.
We investigated inhibition of HMG-CoA synthase in more detail. Modification at the ligandable cysteiner esidues was detected and this interaction led to inhibition of the enzyme activity.HMG-CoA synthase inhibition by modification of C111 using the human HMG-CoA synthase inhibitor hymeglusin has been described, but this inhibitor suffers from as hort half-life of the thioester in the covalent protein adduct. [27] Therefore,p ermanent covalent inhibition by the low promiscuity compound EN106 is av ery promising starting point to explore the antibiotic potential of this protein. [25] This case study demonstrates that our map of ligandable cysteines is an excellent resource to quickly identify residues that can be targeted in af unctionally relevant manner.
Taken together, our isoDTB tags are important new tools for residue-specific proteomics in bacterial systems.T hey allowed the investigation of the bacterial cysteinome globally and should be transferable to studying other amino acids in as traightforward manner. [8] Thec ysteines that were characterized to bind to covalent ligands in this study serve as the foundation for the development of covalent inhibitors that could lead to antibiotics with totally new modes-of-action.
